The deal will expand access to image-guided therapeutic devices that treat cardiac and peripheral vascular disease.
Carefully conducted research can help a manufacturer successfully achieve strategic objectives.
The settlement is one of a few that the company has made within the past several months.
An electrical test failure code could cause the device to fail to initiate therapy.
FDA has categorized the recall as Class I due to the seriousness of the device issue.
The free resource recommends how hospitals can identify and safeguard medical device systems against an attack.
Documentation proves compliance, including when it comes to acceptance activities.
Experts at hospitals state that they need clearer and more organized information from device manufacturers during a recall.
The precision of 3-D printing more accurately addresses the dynamic nature of the human anatomy.
Recalls involving lithium-ion battery components are far more complex and if not handled properly, can have dangerous consequences.